Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
25 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$169.96
Price+0.89%
$1.50
1Y
Price
Market Cap
$8.187b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+18.8%
EBITDA Margin-1.5%
Net Profit Margin-1.5%
Free Cash Flow Margin+18.8%
EBITDA Margin-1.5%
Net Profit Margin-1.5%
Free Cash Flow MarginRevenue
$4.027b
+0.3%
1y CAGR-0.8%
3y CAGR+0.4%
5y CAGREarnings
-$184.650m
-27.9%
1y CAGR-542.5%
3y CAGR-407.5%
5y CAGREPS
-$3.76
-29.2%
1y CAGR-560.7%
3y CAGR-421.2%
5y CAGRBook Value
$2.988b
$7.730b
Assets$4.742b
Liabilities$3.056b
DebtDebt to Assets
39.5%
3.8x
Debt to EBITDAFree Cash Flow
$391.290m
-24.5%
1y CAGR+5.4%
3y CAGR+10.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company